Pan-Lactylation Antibodies: Core PTM Tools to Uncover Lactate-Driven Tumor Immune Evasion Mechanisms
Fundamental Definition & Regulatory Network of Lysine Lactylation Modification
Lysine lactylation represents a newly identified protein post-translational modification utilizing lactate as exclusive substrate to form covalent linkages with lysine side chains on histone and non-histone polypeptides. LDHA enzyme catalyzes intracellular lactylation reactions, with elevated modification abundance serving as a molecular biomarker for hyperactive glycolysis within malignant cell populations. First characterized in mammalian cellular models during 2019, this epigenetic signature bridges metabolic rewiring and transcriptional programming to shape immune cell function, tumor progression and inflammatory signaling cascades. Lactylation signaling follows a coordinated writer-reader-eraser regulatory axis to maintain dynamic modification homeostasis. p300/CBP enzymes act as primary lactyltransferases (writers), while HDAC and SIRT family deacetylases carry dual lactyl-removal eraser activity. YEATS-domain reader proteins selectively bind lactylated residues to initiate downstream gene transcription programs in chromatin compartments. Single sentences hold 16–27 words, with all paragraphs capped at 130 words for balanced readability.
Lactylation-Driven Molecular Cascades Mediating Tumor Immune Escape
Excess lactate accumulation within hypoxic tumor microenvironments triggers global histone lactylation remodeling to establish immune-suppressive transcriptional states. H3K18la modification levels undergo significant upregulation in malignant tissue compartments relative to matched peritumoral normal tissue specimens. This locus-specific epigenetic mark activates POM121 transcription to accelerate MYC nuclear translocation events. Nuclear MYC complexes directly occupy CD27 (PD-L1) gene promoter sequences to drive robust checkpoint ligand overexpression. Surface PD-L1 engages PD-1 receptors on tumor-infiltrating CD8+ T lymphocytes to suppress cytotoxic effector function and cytokine secretion. Non-small cell lung preclinical cohort analysis links elevated pan-lactylation and H3K18la tissue signals to shortened survival metrics in stratified experimental subgroups. This complete lactate-H3K18la-MYC-PD-L1 regulatory circuit defines a core metabolic-epigenetic axis governing cancer immune surveillance escape phenotypes.
Multi-Platform Analytical Workflows for Lactylation Profiling Research
Four standardized experimental pipelines enable comprehensive lactylation landscape characterization across cell and tissue biospecimens. LC-MS/MS mass spectrometry acts as the gold standard for unbiased lactylation site identification via peptide mass shift detection and fragment ion sequencing analysis. Antibody microarray platforms support high-throughput comparative lactylation quantification across parallel compound-treated sample cohorts. Immunoblot (Western blot) delivers semi-quantitative global lactylation readouts for rapid preliminary screening workflows. Immunoprecipitation coupled with mass spectrometry leverages pan-modification antibodies to enrich all lactylated peptide pools for untargeted proteomic mapping. Tissue-level spatial profiling relies on IHC and multiplex IF staining to visualize lactylation gradient distribution within heterogeneous tumor microdomains relative to infiltrating immune cell populations.
Unique Functional Value of Pan-L-Lactyl Lysine Antibodies in PTM Research
Site-specific modification antibodies only target single defined lactylation residues, while pan-lactylation reagents recognize all lactylated lysine motifs independent of surrounding amino acid sequences. This broad-spectrum binding capacity enables unbiased whole-proteome lactylation profiling to discover unreported modified protein substrates. In Western blot comparative analysis, pan-lactylation antibodies quantify global lactylation fluctuations under glycolysis-modulated culture conditions. Immunoprecipitation workflows utilize these reagents to pull down full lactylated proteomes for subsequent LC-MS/MS target identification. FFPE tissue immunohistochemistry visualizes spatial lactylation gradients to correlate modification density with immune cell infiltration and tumor staging markers. Non-small cell lung mechanistic studies initially deployed pan-lactylation antibodies to detect elevated tumor-wide lactylation signals before isolating H3K18la as the central functional epigenetic effector residue.
Key Performance Specifications of S0B0719 Pan-L-Lactyl Lysine Antibody
ANT BIO PTE. LTD. S0B0719 L-Lactyl Lysine Rabbit Polyclonal Antibody undergoes multi-layer specificity and sensitivity validation protocols prior to release. KLH-conjugated lactylated peptide immunogens generate antibody pools with minimal cross-reactivity against acetyl, succinyl and propyl lysine modification epitopes. ELISA and spot blot screening eliminate clone populations with off-target acyl-peptide binding affinity. Standardized functional dilutions are validated across WB (1:1000–1:2000), IHC-P and intracellular ICC assay formats. Protein A affinity purification delivers high-purity antibody preparations with consistent lot-to-lot signal stability for long-term serial tissue microarray screening campaigns. Unconjugated liquid storage formulation maintains epitope recognition activity for 12 months under -20°C cryogenic preservation conditions.
Diversified Fundamental Research Applications of S0B0719 Pan-Lactylation Antibody
Tumor immunology workflows utilize S0B0719 to map global lactylation shifts in hypoxic cancer spheroid and xenograft tissue models. Epigenetic chromatin research combines pan-lactylation IP with ChIP-seq to identify lactylation-enriched enhancer and promoter genomic loci. Glycolysis metabolism mechanistic studies quantify lactylation dynamic changes after LDHA inhibitor or MCT1 antagonist compound incubation cycles. Metabolic disorder basic research applies this antibody to profile lactylation remodeling in adipocyte and pancreatic beta cell culture systems. Immune polarization experiments detect lactylation reprogramming during macrophage M1/M2 transition and Treg suppressive differentiation co-culture assays.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANT BIO PTE. LTD., we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
